Abstract
In this study, we reviewed the history of 38 children with proliferating haemangiomas treated with systemic corticosteroids at our institution between 2000 and 2002. Prednisone was administered at an initial dose of 2 mg/kg per day for 2 weeks followed by a dose of 1 mg/kg per day for another 2–4 weeks and consecutive slow tapering over an additional 4–5 months. For 93% of the children, this protocol was successful in reducing the size of the haemangioma by more than 25% after 2 weeks of treatment. Side effects were moderate and reversible after cessation of therapy.
References
Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon MC, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Bischoff J, North PE, Esterly NB (2005) Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 22:383–406
Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137:1208–1213
Boon LM, MacDonald DM, Mulliken JB (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104:1616–1623
Achauer BM, Chang CJ, Vander Kam VM (1997) Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg 99:1301–1308
Frieden IJ (1997) Which hemangiomas to treat–and how? Arch Dermatol 133:1593–1595
Zarem HA, Edgerton MT (1967) Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 39:76–83
Hasan Q, Tan ST, Xu B, Davis PF (2003) Effects of five commonly used glucocorticoids on haemangioma in vitro. Clin Exp Pharmacol Physiol 30:140–144
Blei F, Wilson EL, Mignatti P, Rifkin DB (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155:568–578
Sadan N, Wolach B (1996) Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 128:141–146
Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137:1208–1213
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rössler, J., Wehl, G. & Niemeyer, C.M. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr 167, 813–815 (2008). https://doi.org/10.1007/s00431-007-0561-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0561-5